var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('4/26 - 8:30 AM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma | \n'); } if (allow) { document.write('
4/9 - 8:30 AM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics Announces Q2 Investor Conference Participation | \n'); } if (allow) { document.write('
3/14 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update | \n'); } if (allow) { document.write('
3/12 - 8:30 AM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease | \n'); } if (allow) { document.write('
3/5 - 8:30 AM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update | \n'); } if (allow) { document.write('
2/28 - 8:30 AM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference | \n'); } if (allow) { document.write('
2/16 - 8:30 AM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia | \n'); } if (allow) { document.write('
1/16 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics Announces Participation in Upcoming Investor Conferences | \n'); } if (allow) { document.write('
1/5 - 11:59 AM \; \; | \n'); } if (allow) { document.write('Friday Sector Laggards: Biotechnology, Hospital & Medical Practitioners [VIDEO] | \n'); } if (allow) { document.write('
1/4 - 4:15 PM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma | \n'); } if (allow) { document.write('
1/4 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry\'s First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma | \n'); } if (allow) { document.write('
1/3 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' |